CK Life Sciences’ Sequencio Therapeutics Appoints Emily Tan as Chief Operating Officer
Source: Media Outreach HONG KONG SAR – Media OutReach Newswire – 18 May 2026 – Sequencio Therapeutics, a subsidiary of CK Life Sciences Int’l., (Holdings) Inc. (“CK Life Sciences”, Stock Code: 0775) today announced the appointment of Emily Tan as Chief Operating Officer. A 30-year biopharmaceutical veteran, Ms Tan will oversee the company’s global operations … Read more